On August 29, 2014, Academician Sang Guowei, the head of the national " major new drug discovery" science and technology major special technology division, academician Wang guangji, the deputy head of the new drug special expert group and the president of the Chinese Pharmaceutical University, responsible experts, Li Songjiao, the researcher of the military medical academy, Wang Junzhi, the researcher of the Chinese Food and Dug Verification Research Institute, Du Guanhua, the researcher of the Chinese Academy of Medical Sciences Drug Research Institute, Sun Xiaobo, the researcher of the Chinese Academy of Medical Sciences Drug Implantation Institute, Ma Ningning, the researcher of the Shenyang Pharmaceutical University, Fang Jianmin, the researcher of Tongji University, Ren Jin, the researcher of Shanghai Pharmaceutical Research of the Chinese Academy of Sciences, Wu peixin, the director of Major Special Department of Science and Education of the Health and Family Planning Commission, etc. They came to Shenzhen CHIPSCREEN BIOSCIENCES for investigation and carried out on-the-spot investigation on the project of CHIPSCREEN BIOSCIENCES innovative drug incubation base, a major scientific and technological project of " major new drug discovery" undertaken by Shenzhen CHIPSCREEN BIOSCIENCES. Jiang Yuyang, the deputy director of the Standing Committee Standing Committee of Shenzhen Municipal People’s Congress, Lu Jian, the director of Shenzhen Science and Technology Innovation Committee Municipal Science and Technology Innovation Committee, Shenzhen Municipal Health and Family Planning Committee and Shenzhen Municipal Food and Drug Administration accompanied the investigation.

At this research meeting, Dr. Lu Xianping, president / chief scientific officer of Shenzhen CHIPSCREEN BIOSCIENCES, gave a brief report on the development of Shenzhen CHIPSCREEN BIOSCIENCES, and gave a detailed report on the research progress of innovative drugs in Shenzhen CHIPSCREEN BIOSCIENCES's innovative drug incubation base and the supporting and guiding role of new drug projects in enterprise innovation activities.

Academician Sang Guowei fully affirmed the independent innovation of Shenzhen CHIPSCREEN BIOSCIENCES, and put forward the ardent hope for the original anti-tumor new drug Chidamide of the enterprise: " your Chidamide is very valuable. Not only is it a new drug, but also it is completely new in theory. I hope that the number of cases treated with single drug will be a little more, and I will choose good combination of drugs to expand the indications. I am very worried about this ...... ".